Physician profile
Eric Lemieux
NPI 1760001267
$2,005.42
in general payments reported to CMS, 2019-2025
8 companies · $1,027 in 2025
The $1,027 reported for 2025 was more than what 88% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $142 · 2024: $837 · 2025: $1,027.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,005.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,005.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $859.67 | 2024-2025 | Cobalt Dr Mri Surescan, Symplicity G3, Corevalve Evolut R |
| Shockwave Medical, INC | $342.00 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Edwards Lifesciences Corporation | $248.66 | 2023-2024 | Sapien 3 Ultra Resilia |
| Boston Scientific Corporation | $182.86 | 2024 | Mamba |
| Teleflex LLC | $178.29 | 2025 | Guideliner |
| Amgen INC. | $99.32 | 2024 | Repatha |
| Philips North America LLC | $73.36 | 2025 | Laser Service and Other |
| Abiomed | $21.26 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Lemieux listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.